This study investigates the efficacy and safety of an investigational medication in adults with moderate-to-severe ulcerative colitis (UC). The purpose of this study is to evaluate how different doses of the investigational medication affect clinical remission in participants with moderate-to-severe UC.Participants will undergo procedures including a screening period and a …
This study investigates the effectiveness, safety, and tolerability of an investigational medication administered subcutaneously compared to a placebo in adults with high-risk asthma. This study is designed for adults between the ages of 18 and 80 who have asthma but are not eligible for biologic treatments.Participants in the study will …
This study investigates an investigational medication for adults with moderate to severe Crohn's Disease. The purpose of this study is to evaluate the efficacy and safety of different doses of the investigational medication compared to a placebo. A placebo is an inactive substance that looks like the investigational medicine/vaccine but …
This study investigates the safety and efficacy of an investigational antibody in protecting against Respiratory Syncytial Virus (RSV) in young children. This study involves neonates and infants aged 0 to 12 months, as well as children up to 24 months of age who are vulnerable to severe RSV disease.Participants will …
This study investigates the effects of an investigational medication on preventing or slowing lung function decline in adults with uncontrolled moderate to severe asthma. Participants in this study will be randomly assigned to one of two study arms: one receiving the investigational medication and the other receiving standard care therapy.Participants …
This study investigates the long-term safety and tolerability of an investigational medication in adults with different forms of multiple sclerosis, including relapsing MS (RMS), primary progressive MS (PPMS), and non-relapsing secondary progressive MS (NRSPMS).Participants in this study will continue to receive the investigational medication in an open-label format, meaning both …
This study investigates the effects of an investigational medication in adults with relapsing forms of multiple sclerosis (MS). The purpose of the study is to compare the annualized relapse rate (ARR) of participants taking the investigational medication versus those taking a daily oral dose of another medication.Participants will undergo regular …
This study investigates the long-term safety and efficacy of an investigational medication in adults with asthma. This study is for participants who have completed previous related studies and aims to continue observing the effects of the investigational medication over an extended period.Participants will continue to receive their asthma treatment as …
This study investigates the long-term safety and efficacy of an investigational medication for treating moderate to severe atopic dermatitis (AD) in participants aged 12 years and older. The study will focus on understanding how the investigational treatment affects individuals who have not responded adequately to previous therapies.Participants in this study …
This study investigates the clinical outcomes of patients with Gaucher disease. The study is observational, meaning it collects data from patients receiving routine care without altering their treatment. It aims to enhance understanding of the disease's variability, progression, and natural history to aid in better therapeutic interventions.Participants will undergo clinical …
